Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-24-087862
Filing Date
2024-08-09
Accepted
2024-08-09 17:05:16
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 tm2421034d2_8k.htm 425 32009
2 EXHIBIT 99-1 tm2421034d2_ex99-1.htm EX-99.1 11399
3 GRAPHIC tm2421034d2_ex99-1img001.jpg GRAPHIC 2132
  Complete submission text file 0001104659-24-087862.txt   48409
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filed by) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Subject) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-40598 | Film No.: 241193875
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)